Clinical trials
Phase 2 Multiple Sclerosis, Chronic Progressive trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Brainstorm-Cell Therapeutics | 1 |
| Clene Nanomedicine | 1 |
| Emmanuelle Waubant, MD PhD | 1 |
| Immunic AG | 1 |
| Kyverna Therapeutics | 1 |
| MediciNova | 1 |
| Moein Amin | 1 |
| NeuroGenesis Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 18 |
| Multiple Sclerosis | 13 |
| Multiple Sclerosis, Relapsing-Remitting | 3 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Diseases | 1 |
| Disease Progression | 1 |
| Fatigue | 1 |
| Nerve Degeneration | 1 |
| Neuroinflammatory Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.